Skip to main content
. 2018 Jul 25;10(2):392–398. doi: 10.1111/jdi.12877

Table 6.

Characteristics of currently followed bullous pemphigoid patients who used dipeptidyl peptidase‐4 inhibitor before diagnosis

No. Sex Age Erythema Antibodies directing BP180 HLA‐DQB1 03:01
Nc16a domain Full‐length
1 M 73 6.86 +
2 F 88 7.42 +
3 F 84 15.04 +
4 M 92 16.26
5 M 61 + 642 +
6 F 86 + 517.3 25.56 +
7 F 84 + 337.4 12.5 +
8 M 80 + 130.2 15.51
9 F 76 + 110 9.59
10 F 75 + 79.6
11 F 83 + 69.7 7.52 +
12 F 54 + 52.5 1.03 +

F, female; M, male.